These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16571126)

  • 21. [Clinical course of the ventilatory function in COPD: analytical study of 160 cases].
    Battikh MH; Ben Sayah MM; Joobeur S; Naouar R; Maatallah A; Rouatbi N; Ben Salem K; El Kamel A
    Tunis Med; 2004 Aug; 82(8):735-41. PubMed ID: 15532768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital readmissions with exacerbation of obstructive pulmonary disease in illicit drug smokers.
    Yadavilli R; Collins A; Ding WY; Garner N; Williams J; Burhan H
    Lung; 2014 Oct; 192(5):669-73. PubMed ID: 25097097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New-onset COPD and Decline in Lung Function Among Wood Dust-Exposed Workers: Re-analysis of a 6-year Follow-up Study.
    Bolund ACS; Miller MR; Jacobsen GH; Sigsgaard T; Schlünssen V
    Ann Work Expo Health; 2018 Nov; 62(9):1064-1076. PubMed ID: 30165410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
    Abramson MJ; Kaushik S; Benke GP; Borg BM; Smith CL; Dharmage SC; Thompson BR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1097-103. PubMed ID: 27307725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
    Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of smoking habits on pulmonary function. Cross-sectional and longitudinal studies in male subjects on medical check-up].
    Omori H; Morimoto Y
    Nihon Kokyuki Gakkai Zasshi; 2004 Apr; 42(4):306-12. PubMed ID: 15114846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma pro-surfactant protein B and lung function decline in smokers.
    Leung JM; Mayo J; Tan W; Tammemagi CM; Liu G; Peacock S; Shepherd FA; Goffin J; Goss G; Nicholas G; Tremblay A; Johnston M; Martel S; Laberge F; Bhatia R; Roberts H; Burrowes P; Manos D; Stewart L; Seely JM; Gingras M; Pasian S; Tsao MS; Lam S; Sin DD;
    Eur Respir J; 2015 Apr; 45(4):1037-45. PubMed ID: 25614175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.
    Guerra S; Halonen M; Vasquez MM; Spangenberg A; Stern DA; Morgan WJ; Wright AL; Lavi I; Tarès L; Carsin AE; Dobaño C; Barreiro E; Zock JP; Martínez-Moratalla J; Urrutia I; Sunyer J; Keidel D; Imboden M; Probst-Hensch N; Hallberg J; Melén E; Wickman M; Bousquet J; Belgrave DC; Simpson A; Custovic A; Antó JM; Martinez FD
    Lancet Respir Med; 2015 Aug; 3(8):613-20. PubMed ID: 26159408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy.
    MacDonald DM; Melzer AC; Collins G; Avihingsanon A; Crothers K; Ingraham NE; Mugerwa H; Ristola M; Shuter J; Kunisaki KM;
    J Acquir Immune Defic Syndr; 2018 Nov; 79(3):e85-e92. PubMed ID: 29985804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories.
    Allinson JP; Hardy R; Donaldson GC; Shaheen SO; Kuh D; Wedzicha JA
    Am J Respir Crit Care Med; 2017 Oct; 196(8):1021-1030. PubMed ID: 28530117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking and obstructive lung dysfunction in persons with chronic spinal cord injury.
    Linn WS; Spungen AM; Gong H; Bauman WA; Adkins RH; Waters RL
    J Spinal Cord Med; 2003; 26(1):28-35. PubMed ID: 12830966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of microspirometry in detecting lowered FEV1 values in current or former cigarette smokers.
    Rytila P; Helin T; Kinnula V
    Prim Care Respir J; 2008 Dec; 17(4):232-7. PubMed ID: 18830521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study.
    Oelsner EC; Balte PP; Bhatt SP; Cassano PA; Couper D; Folsom AR; Freedman ND; Jacobs DR; Kalhan R; Mathew AR; Kronmal RA; Loehr LR; London SJ; Newman AB; O'Connor GT; Schwartz JE; Smith LJ; White WB; Yende S
    Lancet Respir Med; 2020 Jan; 8(1):34-44. PubMed ID: 31606435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of the evidence relating FEV1 decline to giving up smoking.
    Lee PN; Fry JS
    BMC Med; 2010 Dec; 8():84. PubMed ID: 21156048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function.
    Kim W; Moll M; Qiao D; Hobbs BD; Shrine N; Sakornsakolpat P; Tobin MD; Dudbridge F; Wain LV; Ladd-Acosta C; Chatterjee N; Silverman EK; Cho MH; Beaty TH
    JAMA Netw Open; 2021 Dec; 4(12):e2139525. PubMed ID: 34913977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
    Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.